BeiGene Head of R&D Lai Wang On Going Global

 
• By Jessica Merrill

The Chinese company's R&D leader discusses the US regulatory environment for Chinese-made drugs and implications for the cancer-focused company.

China
BeiGene is making progress on its goal to expand outside of China • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards